These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4899685)

  • 1. Studies on Murine Sarcoma Virus: antigenic characterization of Murine Sarcoma Virus induced tumor cells.
    Chuat JC; Berman L; Gunvén P; Klein E
    Int J Cancer; 1969 Jul; 4(4):465-79. PubMed ID: 4899685
    [No Abstract]   [Full Text] [Related]  

  • 2. A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody.
    Cleveland PH; McKhann CF; Johnson K; Nelson S
    Int J Cancer; 1974 Sep; 14(3):417-26. PubMed ID: 4459274
    [No Abstract]   [Full Text] [Related]  

  • 3. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
    Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunofluorescent study of the group-specific antigen of murine leukemia viruses.
    Lejneva OM; Abelev GI
    Int J Cancer; 1970 Sep; 6(2):153-9. PubMed ID: 4320295
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancing effect on tumour growth of humoral antibodies against tumour specific transplantation antigens in tumours induced by murine sarcoma virus(Harvey).
    Bubenik J; Turano A
    Nature; 1968 Nov; 220(5170):928-30. PubMed ID: 5722149
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on murine sarcoma virus. II. Detection of group-specific antigens by immunofluorescence.
    Chuat JC; Lasquellec F; L'Hirondel AM; Boiron M
    Int J Cancer; 1971 Jan; 7(1):101-11. PubMed ID: 4993663
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologic characterization of sarcomas artificially infected with Graffi leukemia virus. II. Studies on the differentiation between viral and new cellular antigens].
    Pasternak L; Pasternak G
    Arch Geschwulstforsch; 1968; 32(4):301-8. PubMed ID: 4308111
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
    Jones DB; Moore M
    Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor specific antigens in viral neoplasms and in unrelated virus infected tumors.
    Sjögren HO
    Ann Med Exp Biol Fenn; 1966; 44(2):227-31. PubMed ID: 4290659
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: "Wild" type antigens of sarcomata induced by a natural amine sarcoma virus (MSV-FBJ).
    Jones DB; Moore M
    Br J Cancer; 1974 Jan; 29(1):94-5. PubMed ID: 4595171
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M; Pearson G; Pettigrew H; Redmon L; Orr T
    Cancer Res; 1973 Nov; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus.
    Jones JM; Jensen F; Veit B; Feldman JD
    J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics of murine C-type viruses. 3. Antigenic conversion and focus induction.
    Grundner G; Fenyö EM; Klein E
    Int J Cancer; 1974 Mar; 13(3):412-9. PubMed ID: 4362613
    [No Abstract]   [Full Text] [Related]  

  • 15. Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens.
    Fenyö EM; Klein E; Klein G; Swiech K
    J Natl Cancer Inst; 1968 Jan; 40(1):69-89. PubMed ID: 4864597
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus.
    Herberman RB; Nunn ME; Lavrin DH; Asofsky R
    J Natl Cancer Inst; 1973 Nov; 51(5):1509-12. PubMed ID: 4543478
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice.
    Fefer A; McCoy JL; Perk K; Glynn JP
    Cancer Res; 1968 Aug; 28(8):1577-85. PubMed ID: 4876979
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
    Leclerc JC; Gomard E; Levy JP
    Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.